Dermorphin (Ermorphin)

$95.00

Dermorphin — Neuroactive & Opioid Peptide Research

A naturally occurring neuroactive peptide studied around the biology of opioid receptor signaling, pain-processing pathways, and central nervous system communication, with particular interest in its interaction with the body’s μ-opioid receptor system.

Dermorphin is a short peptide originally identified in the skin secretions of certain South American frogs. It demonstrates strong affinity and selectivity for μ-opioid receptors, making it an important research compound for investigating opioid receptor biology, neuronal signaling, and mechanisms involved in pain perception. Dermorphin is not an FDA-approved medication, and its potent opioid-receptor activity distinguishes it from many other peptides discussed within the Shifted Being education library.

Research Focus: μ-Opioid Receptors • Neuroactive Peptides • Pain-Processing Pathways • Central Nervous System Signaling • Receptor Pharmacology • Neuronal Communication

A neuroactive research peptide for those interested in the science of opioid receptor biology, neurological signaling, and the molecular pathways involved in pain perception and central nervous system communication.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.

Dermorphin — Neuroactive & Opioid Peptide Research

A naturally occurring neuroactive peptide studied around the biology of opioid receptor signaling, pain-processing pathways, and central nervous system communication, with particular interest in its interaction with the body’s μ-opioid receptor system.

Dermorphin is a short peptide originally identified in the skin secretions of certain South American frogs. It demonstrates strong affinity and selectivity for μ-opioid receptors, making it an important research compound for investigating opioid receptor biology, neuronal signaling, and mechanisms involved in pain perception. Dermorphin is not an FDA-approved medication, and its potent opioid-receptor activity distinguishes it from many other peptides discussed within the Shifted Being education library.

Research Focus: μ-Opioid Receptors • Neuroactive Peptides • Pain-Processing Pathways • Central Nervous System Signaling • Receptor Pharmacology • Neuronal Communication

A neuroactive research peptide for those interested in the science of opioid receptor biology, neurological signaling, and the molecular pathways involved in pain perception and central nervous system communication.

Educational Disclaimer

This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.